1,3,8-Triazaspiro[4.5]decane-2,4-dione hydrochloride

Catalog No. :
ACKXZQ407
CAS No. :
13625-48-4
Molecular Formula :
C7H12ClN3O2
Molecular Weight :
205.65

IUPAC Name:1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride

1,3,8-Triazaspiro[4.5]decane-2,4-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$103.00Login to see priceInquiryInquiry
5g95%$293.00Login to see priceInquiryInquiry
10g95%$509.00Login to see priceInquiryInquiry
25g95%$898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3,8-Triazaspiro[4.5]decane-2,4-dione hydrochloride
IUPAC Name1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride
MDL No.MFCD08448111
Molecular FormulaC7H12ClN3O2
Molecular Weight205.65
SMILESO=C(N1)NC2(CCNCC2)C1=O.[H]Cl
InChI KeyUSBLZEFCYGBDBO-UHFFFAOYSA-N
Synonym1,3,8-TRIAZA-SPIRO[4.5]DECANE-2,4-DIONE HYDROCHLORIDE;1,3,8-Triaza-Spiro[4.5]Decane-2,4-Dione Hydrochloride(WX101906);1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride (1:1);1,3,8-Triazaspiro[4.5]decane-2,4-dione dihydrochloride
CAS No.13625-48-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKXZQ407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIRZE105 route compound structure diagram
    ACIRZE10528121-73-5 In Stock
  2. Then
  3. ACKXZQ407 route product structure diagram
    ACKXZQ40713625-48-4
Inquiry

2. ACKXZQ407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCDGJ615 route compound structure diagram
    ACCDGJ615183673-70-3 In Stock
  2. Then
  3. ACKXZQ407 route product structure diagram
    ACKXZQ40713625-48-4
Inquiry

Comments (0)